The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

innohep 14,000 IU in 0.7 ml, solution for injection

PCO Manufacturing Ltd.PPA0465/499/004

Main Information

Trade Nameinnohep 14,000 IU in 0.7 ml, solution for injection
Active SubstancesTinzaparin sodium
Dosage FormSolution for injection
Licence HolderPCO Manufacturing Ltd.
Licence NumberPPA0465/499/004

Group Information

ATC CodeB01AB Heparin group
B01AB10 tinzaparin


License statusAuthorised
Licence Issued16/06/2023
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back